Creat Group Company has acquired 1 company. A total of 1 acquisition came from private equity firms.
Creat Group Company’s largest acquisition to date was in 2016, when it acquired Bio Products Laboratory for $1.3B. The Company’s most targeted sectors include life science (100%).
B21 floor, Lead International Jia No.2,
Beijing,
100102
China,
+86 10 8472 1992
www.creatgroup.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2016-05-18 |
BPL · Life Science
Hertfordshire, United Kingdom · www.bpl.co.uk BPL is a manufacturer of plasma-derived protein therapies. The company exports to more than 45 countries worldwide. BPL has over 60 years of experience developing and manufacturing plasma-derived therapies since being established as part of the Lister Institute in 1950, and currently markets a wide range of products including coagulation factors, human immunoglobulins, and albumin. BPL is committed to continued investment in research and development to maintain its key position as a reliable supplier of high-quality products to patients and healthcare providers worldwide. |
1,262 | Add-on Acquisition |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
